StockDrifts LogoStockDrifts

Chicago Capital Management 13F Portfolio

Portfolio Manager
Chicago Capital Management, LLC
Performance
+37.15% (2026 Q2)
AUM (13F)
$112.30M
# of Holdings
27
Performance Rank
Allocation (Top 20)
43.13%
Latest filing
Q2 2026

Chicago Capital Management, LLC Holdings Map

Top 12 Chicago Capital Management, LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
NUVL
NUVALENT INC
9.84%115.5K$11.1Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 115.5K shares
$110.11(+12.58%)
2026-06-30
APGE
APOGEE THERAPEUTICS INC
8.73%97.1K$9.8Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 97.1K shares
$105.72(+27.34%)
2026-06-30
GTLS
CHART INDS INC
7.44%53.0K$8.4M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 53.0K shares2026-Q2: 53.0K shares
$144.31(+45.45%)
2026-06-30
TMHC
TAYLOR MORRISON HOME CORP
6.39%133.0K$7.2Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 133.0K shares
$64.47(+12.37%)
2026-06-30
CPRX
CATALYST PHARMACEUTICALS INC
2.61%122.7K$2.9Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 122.7K shares
$27.61(+14.07%)
2026-06-30
ALOT
ASTRONOVA INC
2.54%131.1K$2.8Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 131.1K shares
$18.88(+53.03%)
2026-06-30
ESPR
ESPERION THERAPEUTICS INC NE
2.32%830.9K$2.6Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 830.9K shares
$2.89(+10.21%)
2026-06-30
TECH
BIO-TECHNE CORP
1.8%37.5K$2.0Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 37.5K shares
$61.35(+17.64%)
2026-06-30
TBRG
TRUBRIDGE INC
0.61%34.7K$686Knew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 34.7K shares
$20.10(+30.51%)
2026-06-30
STEL
STELLAR BANCORP INC
0.3%11.6K$342Knew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 11.6K shares
$37.67(+4.38%)
2026-06-30

About Chicago Capital Management, LLCโ€™s portfolio

Chicago Capital Management, LLC reports $112.30M in US-listed equity holdings across 27 positions in its most recent 13F filing. Its largest disclosed positions are NUVL (9.8%), APGE (8.7%) and GTLS (7.4%). The top 20 holdings account for 43.13% of reported assets. Its disclosed equity book has returned +100.73% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
NUVL โ€” 22.8% ($11.05M)APGE โ€” 20.2% ($9.81M)GTLS โ€” 17.3% ($8.36M)TMHC โ€” 14.8% ($7.17M)CPRX โ€” 6.1% ($2.93M)ALOT โ€” 5.9% ($2.85M)ESPR โ€” 5.4% ($2.61M)TECH โ€” 4.2% ($2.02M)TBRG โ€” 1.4% ($685.8K)STEL โ€” 0.7% ($342.4K)Other โ€” 1.3% ($613.0K)
99%in top 10
  • NUVL22.8%
  • APGE20.2%
  • GTLS17.3%
  • TMHC14.8%
  • CPRX6.1%
  • ALOT5.9%
  • ESPR5.4%
  • TECH4.2%
  • TBRG1.4%
  • STEL0.7%
  • Other1.3%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
10
NUVLNUVALENT INC9.8%
APGEAPOGEE THERAPEUTICS INC8.7%
TMHCTAYLOR MORRISON HOME CORP6.4%
CPRXCATALYST PHARMACEUTICALS INC2.6%
+6 opened

Unlock alerts, watchlists & AI chat

Sign up free to track Chicago Capital Management, LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Chicago Capital Management, LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1580162). View Chicago Capital Management, LLCโ€™s 13F filings on SEC

More 13F analyses

View all